-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Gilead Sciences with Equal-Weight Rating, Announces Price Target of $155

Benzinga·02/20/2026 14:58:23
Listen to the news
Barclays analyst Emily Field initiates coverage on Gilead Sciences (NASDAQ:GILD) with a Equal-Weight rating and announces Price Target of $155.